Abstract:The burden of sepsis as a leading cause of global morbidity and mortality is well documented. Sepsis results in high resource utilization and increasing healthcare costs often leaving survivors with life-long disabilities. Numerous novel treatment modalities have often failed in clinical trials in part, because of the heterogeneity of the disease process. These failures have highlighted the critical role that sepsis prevention and early detection play in treatment. Early recognition and prompt initiation of treatment offers the opportunity to intervene before multiple organ system failure commences. Research in the adult patient realm has made great strides with consensus definitions and work to identify biomarkers. In other areas of adult-focused research, emerging technologies have allowed for targeted therapeutics offering "precision" (or "personalized") medicine. As with many areas of medicine, research benefiting our most vulnerable patients, namely neonates and children, has lagged that of adult populations. Unfortunately, newborns and children bear a large share of the sepsis burden especially regarding mortality. 1,2 In this issue of Pediatric Research , Dr. Wang and colleagues have published their manuscript titled "Elevated Total Bile Acid Levels as an Independent Predictor of Mortality in Pediatric Sepsis". 3 In this retrospective analysis, the authors managed to perform a case-control study with 702 septic children (538 survivors and 164 non-survivors) admitted to a single pediatric intensive care unit (PICU) over a 5-year period. Importantly, the authors included an additional 269 non-infected controls that certainly strengthens the study. The authors conclude that serum total bile acids (TBA) appear to be an effective independent biomarker for predicting mortality in children with sepsis. Using a clinical model that identified TBA elevations greater than 17.9 μmol/L was an independent predictor of sepsis mortality with an AUC > 0.842, 54.9% sensitivity, and 96% specificity. Compared to control patients and sepsis survivors, the authors observed greater fluctuations and higher TBA values during hospitalization and at the time of death in the non-survivor cohort. Importantly, we believe that this study provides value by addressing two of the aforementioned challenges of pediatric sepsis – namely defining pediatric sepsis and evaluation for possible biomarkers. Wang et al. utilize the newly developed Phoenix-4 criteria to identify their septic cohort and investigate total bile acid levels as a potential biomarker. Defining sepsis across the age spectrum has been a longstanding challenge. Without clear cut age-specific definitions, treatment of sepsis in pediatric populations has relied heavily on a balance of clinical gestalt and available adult evidence. While numerous biomarkers have been investigated in pediatric sepsis, many lack the desired sensitivity and specificity or have not been widely validated in clinical use.

In Vivo Analysis of Tissue S-Nitrosothiols in Pediatric Sepsis

Longitudinal Profiles of Metabolism and Bioenergetics Associated with Innate Immune Hormonal Inflammatory Responses and Amino‐Acid Kinetics in Severe Sepsis and Systemic Inflammatory Response Syndrome in Children

Evaluating small vessel neutrophils as a marker for sepsis

Is There a Role of Presepsin as a Novel Biomarker in Pediatric Sepsis?

Plasma Free Thiol Levels during Early Sepsis Predict Future Renal Function Decline

Examining bile acids in pediatric sepsis – a step in the right direction

Hydrogen Sulfide in Exhaled Gases From Ventilated Septic Neonates and Children: A Preliminary Report

Comparative Analysis of C-reactive Protein and Procalcitonin as Biomarkers for Prognostic Assessment in Pediatric Sepsis

Serum Levels of Vitamin C and Thiamin in Children With Suspected Sepsis: A Prospective Observational Cohort Study

Validation of the Vasoactive-Inotropic Score in Pediatric Sepsis

S -Nitrosoprotein Formation and Localization in Endothelial Cells

Presepsin Levels in Pediatric Patients with Fever and Suspected Sepsis: A Pilot Study in an Emergency Department

Prognostic and predictive value of endothelial dysfunction biomarkers in sepsis-associated acute kidney injury: risk-stratified analysis from a prospective observational cohort of pediatric septic shock

Selenoprotein P, Rather than Glutathione Peroxidase, as a Potential Marker of Septic Shock and Related Syndromes

Evaluation of Systemic Inflammatory Response Syndrome-Negative Sepsis from a Chinese Regional Pediatric Network

Serial measurements of SIRS and SEP scores to identify unique phenotypes of sepsis

Novel Echocardiogram Analysis of Cardiac Dysfunction is Associated with Mortality in Pediatric Sepsis

Potential biomarkers used for risk estimation of pediatric sepsis-associated organ dysfunction and immune dysregulation

GC-ECNICI-MS analysis of S-nitrosothiols and nitroprusside after treatment with aqueous sulphide (S2-) and derivatization with pentafluorobenzyl bromide: Evidence of S-transnitrosylation and formation of nitrite and nitrate

Automated Online Solid-Phase Derivatization for Sensitive Quantification of Endogenous S-Nitrosoglutathione and Rapid Capture of Other Low-Molecular-Mass S-Nitrosothiols

Serum Phenylalanine, Myo-inositol, and 1,5-Anhydrohexitol biosignature differentiate neonatal sepsis cases from controls